| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A complex proinflammatory cascade mediates the activation of HSCs upon LPS exposure in vivo
|
Demel, Uta Margareta
|
|
|
6 |
11 |
p. 3513-3528
|
article
|
| 2 |
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
|
Ferguson, Daniel C.
|
|
|
6 |
11 |
p. 3386-3397
|
article
|
| 3 |
Anakinra utilization in refractory pediatric CAR T-cell associated toxicities
|
Diorio, Caroline
|
|
|
6 |
11 |
p. 3398-3403
|
article
|
| 4 |
A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas
|
Munshi, Manit
|
|
|
6 |
11 |
p. 3332-3338
|
article
|
| 5 |
A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
|
Lee, Christine S.M.
|
|
|
6 |
11 |
p. 3494-3506
|
article
|
| 6 |
A predictive model for bone marrow disease in cytopenia based on noninvasive procedures
|
Træden, Dicte
|
|
|
6 |
11 |
p. 3541-3550
|
article
|
| 7 |
Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C
|
Jiang, Miao
|
|
|
6 |
11 |
p. 3304-3314
|
article
|
| 8 |
CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
|
Giustiniani, Jérôme
|
|
|
6 |
11 |
p. 3507-3512
|
article
|
| 9 |
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
|
Okamoto, Akinao
|
|
|
6 |
11 |
p. 3230-3233
|
article
|
| 10 |
Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping
|
Jean, Jeffrey
|
|
|
6 |
11 |
p. 3343-3346
|
article
|
| 11 |
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
|
Cook, Joselle
|
|
|
6 |
11 |
p. 3268-3279
|
article
|
| 12 |
Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination
|
Lee, Agnes Y.Y.
|
|
|
6 |
11 |
p. 3315-3320
|
article
|
| 13 |
Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19
|
Henderson, Michael W.
|
|
|
6 |
11 |
p. 3367-3377
|
article
|
| 14 |
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML
|
Stasik, Sebastian
|
|
|
6 |
11 |
p. 3294-3303
|
article
|
| 15 |
Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes
|
Stomper, Julia
|
|
|
6 |
11 |
p. 3551-3555
|
article
|
| 16 |
Dissecting platelet proteomics to understand the pathophysiology of immune thrombocytopenia: studies in mouse models
|
Martínez-Botía, Patricia
|
|
|
6 |
11 |
p. 3529-3534
|
article
|
| 17 |
Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients
|
Alshalani, Abdulrahman
|
|
|
6 |
11 |
p. 3260-3267
|
article
|
| 18 |
Editorial Board
|
|
|
|
6 |
11 |
p. i
|
article
|
| 19 |
Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia
|
Epstein-Peterson, Zachary D.
|
|
|
6 |
11 |
p. 3433-3439
|
article
|
| 20 |
Enhanced hepatic clearance of hyposialylated platelets explains thrombocytopenia in GNE-related macrothrombocytopenia
|
Noordermeer, Tessa
|
|
|
6 |
11 |
p. 3347-3351
|
article
|
| 21 |
Extracellular vesicle proteomic analysis leads to the discovery of HDGF as a new factor in multiple myeloma biology
|
Hoelzinger, Dominique B.
|
|
|
6 |
11 |
p. 3458-3471
|
article
|
| 22 |
G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL
|
Iacobucci, Ilaria
|
|
|
6 |
11 |
p. 3255-3259
|
article
|
| 23 |
Genetic variants of PKLR are associated with acute pain in sickle cell disease
|
Wang, Xunde
|
|
|
6 |
11 |
p. 3535-3540
|
article
|
| 24 |
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia
|
Yamato, Genki
|
|
|
6 |
11 |
p. 3207-3219
|
article
|
| 25 |
Hard-wired biases in trials: maintenance azacitidine in patients with acute myeloid leukemia and framework for future trials
|
Olivier, Timothée
|
|
|
6 |
11 |
p. 3329-3331
|
article
|
| 26 |
Identification of novel γ-globin inducers among all potential erythroid druggable targets
|
Yu, Lei
|
|
|
6 |
11 |
p. 3280-3285
|
article
|
| 27 |
Lasting shift in the gut microbiota in patients with acute myeloid leukemia
|
Rashidi, Armin
|
|
|
6 |
11 |
p. 3451-3457
|
article
|
| 28 |
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
|
Shapiro, Amy D.
|
|
|
6 |
11 |
p. 3422-3432
|
article
|
| 29 |
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma
|
Puig, Noemí
|
|
|
6 |
11 |
p. 3234-3239
|
article
|
| 30 |
Megakaryocyte/platelet-derived TGF-β1 inhibits megakaryopoiesis in bone marrow by regulating thrombopoietin production in liver
|
Gostynska, Sandra
|
|
|
6 |
11 |
p. 3321-3328
|
article
|
| 31 |
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial
|
Broers, Annoek E.C.
|
|
|
6 |
11 |
p. 3378-3385
|
article
|
| 32 |
Prediction of outcomes after second-line treatment for acute graft-versus-host disease
|
Vo, Phuong
|
|
|
6 |
11 |
p. 3220-3229
|
article
|
| 33 |
Proteomic identification of proliferation and progression markers in human polycythemia vera stem and progenitor cells
|
Tan, Ge
|
|
|
6 |
11 |
p. 3480-3493
|
article
|
| 34 |
SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa
|
Childers, Kenneth C.
|
|
|
6 |
11 |
p. 3240-3254
|
article
|
| 35 |
Shared and distinct genetic features in human and canine B-cell lymphomas
|
Coyle, Krysta Mila
|
|
|
6 |
11 |
p. 3404-3409
|
article
|
| 36 |
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
|
Marques-Piubelli, Mario L.
|
|
|
6 |
11 |
p. 3286-3293
|
article
|
| 37 |
Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
|
Di, Mengyang
|
|
|
6 |
11 |
p. 3339-3342
|
article
|
| 38 |
Sézary syndrome patient–derived models allow drug selection for personalized therapy
|
Gallardo, Fernando
|
|
|
6 |
11 |
p. 3410-3421
|
article
|
| 39 |
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
|
Daly, John
|
|
|
6 |
11 |
p. 3352-3366
|
article
|
| 40 |
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
|
Schimmer, Roman R.
|
|
|
6 |
11 |
p. 3201-3206
|
article
|
| 41 |
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia
|
Barr, Paul M.
|
|
|
6 |
11 |
p. 3440-3450
|
article
|
| 42 |
Validation and clinical application of transactivation assays for RUNX1 variant classification
|
Decker, Melanie
|
|
|
6 |
11 |
p. 3195-3200
|
article
|
| 43 |
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
|
Phillips, Tycel
|
|
|
6 |
11 |
p. 3472-3479
|
article
|
Journal description